Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,947,000 | 975,000 | 4,507,000 | 1,631,000 | 2,029,000 |
| Depreciation Amortization | 637,000 | 789,000 | 382,000 | 376,000 | 467,000 |
| Income taxes - deferred | 45,000 | 453,000 | -204,000 | -347,000 | -542,000 |
| Accounts receivable | -429,000 | -431,000 | -803,000 | -942,000 | -252,000 |
| Other Working Capital | 217,000 | 2,145,000 | -1,152,000 | -735,000 | 242,000 |
| Other Operating Activity | 1,649,000 | 1,344,000 | 328,000 | 2,122,000 | 1,204,000 |
| Operating Cash Flow | $7,066,000 | $5,275,000 | $3,058,000 | $2,105,000 | $3,148,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 74,000 | 979,000 | 1,720,000 | -349,000 | -1,624,000 |
| PPE Investments | -951,000 | -1,055,000 | -1,215,000 | -820,000 | -526,000 |
| Net Acquisitions | -1,123,000 | 10,000 | 975,000 | -403,000 | 3,366,000 |
| Investing Cash Flow | $-2,000,000 | $-66,000 | $1,480,000 | $-1,572,000 | $1,216,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -543,000 | 727,000 | 125,000 | -449,000 | 244,000 |
| Debt Issued | 0 | 1,488,000 | 0 | 1,268,000 | 0 |
| Debt Repayment | -5,000 | -1,224,000 | -15,000 | -1,957,000 | -676,000 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 288,000 |
| Common Stock Repurchased | -320,000 | -2,469,000 | -231,000 | 0 | 0 |
| Dividend Paid | -2,613,000 | -2,577,000 | -2,547,000 | -2,477,000 | -2,398,000 |
| Other Financing Activity | -54,000 | -22,000 | 15,000 | -9,000 | 105,000 |
| Financing Cash Flow | $-3,535,000 | $-4,077,000 | $-2,653,000 | $-3,624,000 | $-2,437,000 |
| Exchange Rate Effect | -41,000 | 52,000 | -33,000 | -95,000 | 58,000 |
| Beginning Cash Position | 5,421,000 | 4,237,000 | 2,385,000 | 5,571,000 | 3,586,000 |
| End Cash Position | 6,911,000 | 5,421,000 | 4,237,000 | 2,385,000 | 5,571,000 |
| Net Cash Flow | $1,490,000 | $1,184,000 | $1,852,000 | $-3,186,000 | $1,985,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,066,000 | 5,275,000 | 3,058,000 | 2,105,000 | 3,148,000 |
| Capital Expenditure | -951,000 | -1,055,000 | -1,215,000 | -820,000 | -526,000 |
| Free Cash Flow | 6,115,000 | 4,220,000 | 1,843,000 | 1,285,000 | 2,622,000 |